1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ELEVATION ONCOLOGY INC
Elevation Oncology Inc XNAS: ELEV

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Elevation Oncology Inc

The latest disclosure was made by R. Michael Carruthers in Elevation Oncology Inc where a trade of 35,000 Stock Option (Right to Buy) done was reported to US exchanges on July 23, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
R. Michael Carruthers Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
R. Michael Carruthers Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 47,330 0 - - Stock Option (Right to Buy)
R. Michael Carruthers Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 15,619 0 - - Stock Option (Right to Buy)
R. Michael Carruthers Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 31,238 0 - - Stock Option (Right to Buy)
R. Michael Carruthers Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Timothy P. Clackson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 15,619 0 - - Stock Option (Right to Buy)
Timothy P. Clackson Director 23 Jul 2025 47,330 0 - 0.4 17,039 Common Stock
Timothy P. Clackson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Timothy P. Clackson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Timothy P. Clackson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 31,238 0 - - Stock Option (Right to Buy)
Steven A. Elms Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 15,619 0 - - Stock Option (Right to Buy)
Steven A. Elms Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 31,238 0 - - Stock Option (Right to Buy)
Steven A. Elms Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Steven A. Elms Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Steven A. Elms Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 31,238 0 - - Stock Option (Right to Buy)
Alan B. Sandler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Alan B. Sandler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 55,000 0 - - Stock Option (Right to Buy)
Alan B. Sandler Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 79,327 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 79,327 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER 23 Jul 2025 37,957 0 - 0.4 13,665 Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 275,000 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 225,000 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 53,433 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 28,800 0 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 52,500 0 - - Stock Option (Right to Buy)
Darcy Mootz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 55,000 0 - - Stock Option (Right to Buy)
Darcy Mootz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Darcy Mootz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Jul 2025 35,000 0 - - Stock Option (Right to Buy)
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jun 2025 12,560 0 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. 16 Jun 2025 4,627 145,085 - 0.4 1,783 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jun 2025 12,560 149,712 - - Common Stock
R. Michael Carruthers Director 05 Jun 2025 35,000 35,000 - - Stock Option (Right to Buy)
Timothy P. Clackson Director 05 Jun 2025 35,000 35,000 - - Stock Option (Right to Buy)
Steven A. Elms Director 05 Jun 2025 35,000 35,000 - - Stock Option (Right to Buy)
Alan B. Sandler Director 05 Jun 2025 35,000 35,000 - - Stock Option (Right to Buy)
Darcy Mootz Director 05 Jun 2025 35,000 35,000 - - Stock Option (Right to Buy)
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2025 6,250 139,455 - - Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2025 6,250 68,750 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.30 per share. 15 May 2025 2,303 137,152 - 0.3 690 Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 May 2025 784 10,075 - 0.3 235 Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 May 2025 300 2,100 - - Restricted Stock Unit
Tammy Furlong CHIEF FINANCIAL OFFICER 15 May 2025 2,343 25,782 - - Restricted Stock Unit
Tammy Furlong CHIEF FINANCIAL OFFICER 15 May 2025 2,643 10,859 - - Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2025 12,562 12,560 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.53 per share. 16 Mar 2025 4,628 133,205 - 0.5 2,466 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2025 12,562 137,833 - - Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 25,000 134,482 - - Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 15 Feb 2025 9,211 125,271 - 0.7 6,187 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2025 800,000 800,000 - - Stock Option (Right to Buy)
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 25,000 75,000 - - Restricted Stock Unit
David Dornan CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 9,375 9,375 - - Common Stock
David Dornan CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 15 Feb 2025 4,152 5,223 - 0.7 2,789 Common Stock
David Dornan CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 9,375 28,125 - - Restricted Stock Unit
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 17,500 52,500 - - Restricted Stock Unit
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 17,500 17,500 - - Common Stock
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. 15 Feb 2025 5,189 12,311 - 0.7 3,485 Common Stock
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2025 275,000 275,000 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2025 275,000 275,000 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2025 9,375 28,125 - - Restricted Stock Unit
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2025 300 2,400 - - Restricted Stock Unit
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2025 9,375 10,785 - - Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2025 2,780 8,005 - 0.7 1,867 Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2025 300 8,305 - - Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2025 89 8,216 - 0.7 60 Common Stock
J. Ferra Joseph Director, CHIEF EXECUTIVE OFFICER 16 Dec 2024 12,563 114,111 - - Common Stock
J. Joseph Ferra Director, CHIEF EXECUTIVE OFFICER 16 Dec 2024 12,563 25,122 - - Restricted Stock Unit
J. Ferra Joseph Director, CHIEF EXECUTIVE OFFICER 16 Dec 2024 4,629 109,482 - 0.6 2,963 Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Nov 2024 98 1,410 - 0.5 52 Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Nov 2024 300 1,508 - - Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Nov 2024 300 2,700 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Sep 2024 12,562 37,685 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Sep 2024 4,628 101,548 - 0.6 2,823 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Sep 2024 12,562 106,176 - - Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Aug 2024 89 1,208 - 0.7 64 Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Aug 2024 300 1,297 - - Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Aug 2024 300 3,000 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Jun 2024 12,562 50,247 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Jun 2024 4,628 93,614 - 3.2 14,948 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Jun 2024 12,562 98,242 - - Common Stock
R. Michael Carruthers Director 13 Jun 2024 35,000 35,000 - - Stock Option (Right to Buy)
Timothy P. Clackson Director 13 Jun 2024 35,000 35,000 - - Stock Option (Right to Buy)
Steven A. Elms Director 13 Jun 2024 35,000 35,000 - - Stock Option (Right to Buy)
Alan B. Sandler Director 13 Jun 2024 35,000 35,000 - - Stock Option (Right to Buy)
Darcy Mootz Director 13 Jun 2024 35,000 35,000 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER 15 May 2024 300 3,300 - - Restricted Stock Unit
Tammy Furlong CHIEF FINANCIAL OFFICER 15 May 2024 300 1,097 - - Common Stock
Tammy Furlong CHIEF FINANCIAL OFFICER 15 May 2024 100 997 - 3.7 373 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Mar 2024 12,562 62,809 - - Restricted Stock Unit
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Mar 2024 4,773 85,680 - 4.4 20,953 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Mar 2024 12,562 90,453 - - Common Stock
Alan B. Sandler Director 29 Feb 2024 55,000 55,000 - - Stock Option (Right to Buy)
Furlong Tammy CHIEF FINANCIAL OFFICER 15 Feb 2024 225,000 225,000 - - Stock Option (Right to Buy)
Furlong Tammy CHIEF FINANCIAL OFFICER 15 Feb 2024 403 797 - 2.8 1,116 Common Stock
Malyvanh Jansen Valerie CHIEF MEDICAL OFFICER 15 Feb 2024 225,000 225,000 - - Stock Option (Right to Buy)
Valerie Jansen Malyvanh CHIEF MEDICAL OFFICER 15 Feb 2024 70,000 70,000 - - Restricted Stock Unit
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2024 1,200 1,200 - - Common Stock
Dornan David CHIEF SCIENTIFIC OFFICER 15 Feb 2024 37,500 37,500 - - Restricted Stock Unit
Joseph Ferra J. Director, CHIEF EXECUTIVE OFFICER 15 Feb 2024 600,000 600,000 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2024 37,500 37,500 - - Restricted Stock Unit
David Dornan CHIEF SCIENTIFIC OFFICER 15 Feb 2024 225,000 225,000 - - Stock Option (Right to Buy)
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 15 Feb 2024 100,000 100,000 - - Restricted Stock Unit
Tammy Furlong CHIEF FINANCIAL OFFICER 15 Feb 2024 1,200 3,600 - - Restricted Stock Unit
Darcy Mootz Director 18 Jan 2024 55,000 55,000 - - Stock Option (Right to Buy)
J. Joseph Ferra Director, CHIEF EXECUTIVE OFFICER 16 Dec 2023 12,563 82,664 - - Common Stock
J. Joseph Ferra Director, CHIEF EXECUTIVE OFFICER 16 Dec 2023 4,773 77,891 - 0.5 2,434 Common Stock
Joseph J. Ferra Director, CHIEF EXECUTIVE OFFICER 16 Dec 2023 12,563 75,371 - - Restricted Stock Unit
Joseph J. Ferra CHIEF EXECUTIVE OFFICER 12 Jul 2023 35,000 35,000 - - Stock Option (Right to Buy)
Tammy Furlong CHIEF FINANCIAL OFFICER 12 Jul 2023 53,433 53,433 - - Stock Option (Right to Buy)
R. Michael Carruthers Director 16 Jun 2023 31,238 31,238 - - Stock Option (Right to Buy)
Timothy P. Clackson Director 16 Jun 2023 31,238 31,238 - - Stock Option (Right to Buy)
Joseph J. Ferra INTERIM CEO & CFO 16 Jun 2023 4,773 62,312 - 1.5 7,016 Common Stock
Joseph J. Ferra INTERIM CEO & CFO 16 Jun 2023 12,563 100,496 - - Restricted Stock Unit
Joseph J. Ferra INTERIM CEO & CFO 16 Jun 2023 12,563 67,085 - - Common Stock
Lori Hu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 31,238 31,238 - - Stock Option (Right to Buy)
Colin Walsh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 31,238 31,238 - - Stock Option (Right to Buy)
Joseph J. Ferra INTERIM CEO & CFO 16 Mar 2023 12,563 113,059 - - Restricted Stock Unit
Joseph J. Ferra INTERIM CEO & CFO 16 Mar 2023 4,773 54,522 - 2.4 11,217 Common Stock
Joseph J. Ferra INTERIM CEO & CFO 16 Mar 2023 12,563 59,295 - - Common Stock
Joseph J. Ferra INTERIM CEO & CFO 15 Feb 2023 270,000 270,000 - - Stock Option (Right to Buy)
David Dornan CHIEF SCIENTIFIC OFFICER 15 Feb 2023 130,000 130,000 - - Stock Option (Right to Buy)
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER 15 Feb 2023 130,000 130,000 - - Stock Option (Right to Buy)
Joseph J. Ferra INTERIM CEO & CFO 06 Jan 2023 30,000 30,000 - - Stock Option (Right to Buy)
Joseph J. Ferra INTERIM CEO & CFO 06 Jan 2023 240,000 240,000 - - Stock Option (Right to Buy)
David Dornan CHIEF SCIENTIFIC OFFICER 06 Jan 2023 130,000 130,000 - - Stock Option (Right to Buy)
Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER 06 Jan 2023 130,000 130,000 - - Stock Option (Right to Buy)
R. Michael Carruthers Director 17 Jun 2022 15,619 15,619 - - Stock Option (Right to Buy)
Timothy P. Clackson Director 17 Jun 2022 15,619 15,619 - - Stock Option (Right to Buy)
Timothy P. Clackson Director 17 Jun 2022 31,553 15,777 - 0 Common Stock
Lori Hu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 15,619 15,619 - - Stock Option (Right to Buy)
Colin Walsh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 15,619 15,619 - - Stock Option (Right to Buy)
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 12,562 125,622 - - Restricted Stock Unit
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 12,562 51,505 - - Common Stock
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 4,773 46,732 - 0.9 4,534 Common Stock
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 50,249 150,746 - - Restricted Stock Unit
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 12,562 138,184 - - Restricted Stock Unit
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 50,249 50,249 - - Common Stock
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 19,095 31,154 - 1.3 24,060 Common Stock
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 12,562 43,716 - - Common Stock
Joseph J. Ferra CHIEF FINANCIAL OFFICER 16 Jun 2022 4,773 38,943 - 1.2 5,966 Common Stock
David Dornan Chief Scientific Officer 14 Mar 2022 230,000 230,000 - - Employee Stock Option (right to buy)
Joseph J. Ferra Chief Financial Officer 14 Feb 2022 60,000 60,000 - - Employee Stock Option (Right to Buy)
Shawn Leland Director, President, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 186,500 186,500 - - Employee Stock Option (Right to Buy)
Valerie Malyvanh Jansen Chief Medical Officer 14 Feb 2022 60,000 60,000 - - Employee Stock Option (Right to Buy)
Valerie Malyvanh Jansen Chief Medical Officer 19 Oct 2021 40,000 40,000 - - Employee Stock Option (Right to Buy)
Joseph J. Ferra Chief Financial Officer 24 Jun 2021 249,104 249,104 - - Stock Option (Right to Buy)
Joseph J. Ferra Chief Financial Officer 24 Jun 2021 200,995 200,995 - - Restricted Stock Unit (RSU)
Richard S. Gaster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 31,238 31,238 - - Director Stock Option (Right to Buy)
Lori Hu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 31,238 31,238 - - Director Stock Option (Right to Buy)
Colin Walsh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 31,238 31,238 - - Director Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters